Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 18
Healthy Volunteers: t
View:

• Children with PANS

‣ Age 1-18 at onset of PANS

⁃ Diagnosis of PANS: abrupt onset of OCD or food restriction, and at least two of the following associated symptoms: frequent urination, worsening handwriting/cognition, inattention, anorexia, separation anxiety, oppositionality, irritability/rage outbursts, and emotional lability.

⁃ Patients must live within 90 miles of Stanford University and have a new onset of PANS illness

⁃ Patients must have an established pediatrician within 90 miles of Stanford University for 3 years.

• Healthy Controls

‣ Age 4-18

⁃ No psychiatric diagnosis

Locations
United States
California
Stanford University
RECRUITING
Palo Alto
Contact Information
Primary
Joanne Cheung
pansresearch@stanford.edu
Backup
Ellen Spartz
Time Frame
Start Date: 2013-03
Estimated Completion Date: 2028-03
Participants
Target number of participants: 500
Treatments
PANS group
500 children, 1-18 years old at onset with a strict diagnosis of PANS/PANDAS will be recruited
Health Controls
100 healthy children age- and gender- matched to the PANS group will be recruited
Sponsors
Leads: Stanford University

This content was sourced from clinicaltrials.gov